MX2018000354A - Proceso para la producción de cannabidiol y delta-9-tetrahidrocana binol. - Google Patents

Proceso para la producción de cannabidiol y delta-9-tetrahidrocana binol.

Info

Publication number
MX2018000354A
MX2018000354A MX2018000354A MX2018000354A MX2018000354A MX 2018000354 A MX2018000354 A MX 2018000354A MX 2018000354 A MX2018000354 A MX 2018000354A MX 2018000354 A MX2018000354 A MX 2018000354A MX 2018000354 A MX2018000354 A MX 2018000354A
Authority
MX
Mexico
Prior art keywords
cannabidiol
derivative
cannabidiol compound
tetrahydrocannabinol
delta
Prior art date
Application number
MX2018000354A
Other languages
English (en)
Inventor
Dialer Lukas
Petrovic Denis
Weigl Ulrich
Original Assignee
Noramco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57730761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2018000354(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noramco Inc filed Critical Noramco Inc
Publication of MX2018000354A publication Critical patent/MX2018000354A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Abstract

La presente descripción se refiere a la preparación de un compuesto de cannabidiol y un derivado del mismo; el compuesto de cannabidiol o derivados del mismo pueden prepararse mediante una reacción catalizada por ácido de un di-halo-olivetol adecuadamente seleccionado y sustituido o derivado del mismo con un alqueno cíclico adecuadamente seleccionado y sustituido para producir un compuesto de dihalo-cannabidiol o derivado del mismo; el compuesto de dihalo-cannabidiol o derivado del mismo se puede producir en alto rendimiento, alta estéreoespecificidad, o ambos; entonces puede convertirse bajo condiciones de reducción a un compuesto de cannabidiol o derivado del mismo.
MX2018000354A 2015-07-10 2016-07-01 Proceso para la producción de cannabidiol y delta-9-tetrahidrocana binol. MX2018000354A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562191097P 2015-07-10 2015-07-10
US15/199,528 US10059683B2 (en) 2015-07-10 2016-06-30 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
PCT/US2016/040635 WO2017011210A1 (en) 2015-07-10 2016-07-01 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
MX2018000354A true MX2018000354A (es) 2018-08-15

Family

ID=57730761

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000354A MX2018000354A (es) 2015-07-10 2016-07-01 Proceso para la producción de cannabidiol y delta-9-tetrahidrocana binol.

Country Status (21)

Country Link
US (4) US10059683B2 (es)
EP (2) EP3319952B8 (es)
JP (2) JP6810842B2 (es)
CN (1) CN108137526A (es)
AU (2) AU2016294264B2 (es)
BR (1) BR112018000497A2 (es)
CA (1) CA2992043C (es)
CL (2) CL2018000079A1 (es)
CO (1) CO2018001290A2 (es)
CR (1) CR20180094A (es)
DK (1) DK3319952T3 (es)
EC (1) ECSP18010065A (es)
ES (1) ES2784881T3 (es)
HK (1) HK1255390A1 (es)
IL (1) IL256750A (es)
MX (1) MX2018000354A (es)
MY (1) MY182971A (es)
NZ (1) NZ738925A (es)
PH (1) PH12018500093A1 (es)
PT (1) PT3319952T (es)
WO (1) WO2017011210A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
US10059683B2 (en) * 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
JP2021513553A (ja) * 2018-02-13 2021-05-27 ビートルバング ファーマ リミテッド カンナビノイド誘導体並びにそのコンジュゲート及びその使用
ES2926328T3 (es) * 2018-02-20 2022-10-25 Mymd Pharmaceuticals Inc Plantas de Cannabis sativa modificadas genéticamente y compuestos cannabinoides modificados para tratamiento de adicción a sustancias y otros trastornos
CN112292368B (zh) 2018-06-28 2024-02-02 西姆莱斯有限公司 （+）-大麻素类的合成及其治疗作用
US10736869B2 (en) 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
CN108863768A (zh) * 2018-08-03 2018-11-23 上海华堇生物技术有限责任公司 3,5-二甲氧基苯甲酰氯的制备方法
EP3840854A4 (en) 2018-08-20 2022-06-29 Bessor Pharma, LLC Novel cannabinoids and cannabinoid acids and their derivatives
AU2019335372A1 (en) * 2018-09-05 2021-05-06 Purisys Llc Cannabidiol compositions having modified cannabinoid profiles
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
EP3653596A1 (en) * 2018-11-14 2020-05-20 Indena S.p.A. Continuous flow synthesis of cannabidiol
DE102019104563A1 (de) 2019-02-22 2020-08-27 Chiracon Gmbh Verfahren zur Herstellung von Cannabidiol
CN109970516A (zh) * 2019-03-20 2019-07-05 栾云鹏 一种工业化制备高纯度高收率的大麻酚类物质的合成方法
WO2020214574A1 (en) 2019-04-15 2020-10-22 Trustees Of Boston University One-step flow-mediated synthesis of cannabidiol (cbd) and derivatives
CN111943813B (zh) * 2019-05-17 2023-04-14 上海特化医药科技有限公司 大麻二酚类化合物的制备方法
SG11202112677WA (en) * 2019-05-23 2021-12-30 Kare Chemical Tech Inc Catalytic cannabinoid processes and precursors
JP2022535755A (ja) * 2019-05-31 2022-08-10 ピュリシス・リミテッド・ライアビリティ・カンパニー ハロゲン化ジヒドロキシベンゼン化合物の調製プロセス
EP3983367A1 (en) 2019-06-11 2022-04-20 Symrise AG Synthesis and purification of cannabigerol and its application
WO2020252277A1 (en) * 2019-06-13 2020-12-17 Isomerz, Inc. Making delta 8 thc, delta 10 thc and/or cannabinol from cbd
WO2020252369A1 (en) * 2019-06-14 2020-12-17 Purisys Llc Crystalline cannabigerol
US11542243B1 (en) 2019-09-26 2023-01-03 FusionFarms, LLC Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
WO2021113083A1 (en) 2019-12-06 2021-06-10 JLABS Beauty LLC Topical compositions containing rose oil and cannabidiol and methods of making and using the same
CN115066238A (zh) * 2019-12-27 2022-09-16 海湾医学公司 大麻色原烯和相关大麻素的制备
US20230002425A1 (en) * 2020-01-08 2023-01-05 Chengdu Baiyu Pharmaceutical Co., Ltd. Cannabidiol derivatives, preparation method thereof and use thereof
WO2021139740A1 (zh) * 2020-01-08 2021-07-15 成都百裕制药股份有限公司 四氢大麻酚衍生物及其制备方法和在医药上的应用
CN113087599A (zh) * 2020-01-08 2021-07-09 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用
US20210230113A1 (en) * 2020-01-24 2021-07-29 Perkinelmer Health Sciences, Inc. Cannabinoid derivatives
US10981849B1 (en) * 2020-02-20 2021-04-20 Sci Pharmtech Inc. Method for preparing cannabinoids
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
WO2021181420A1 (en) 2020-03-12 2021-09-16 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Process for the synthesis of cannabidiol and intermediates thereof
IL296861A (en) * 2020-03-31 2022-11-01 Phytotherapeutix Ltd Terpenophenolic compounds and their use
AU2021276680A1 (en) 2020-05-22 2023-01-19 Ilera Derm LLC Compositions for treating acne and dermatological conditions
CN112094257B (zh) * 2020-08-19 2023-08-22 公安部禁毒情报技术中心 一种△-9四氢大麻酚的制备方法
CN112811980B (zh) * 2020-12-01 2022-03-25 山东金城金奥医药科技有限公司 一种绿色光氧化连续制备大麻二酚中间体的方法
EP4263514A2 (en) 2020-12-17 2023-10-25 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use
US11242330B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Organic catalyst and method for preparation of aromatic tricyclic pyrans
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US20220306598A1 (en) * 2021-03-25 2022-09-29 Precision Extraction Corporation Method for highly selective conversion of cbd to delta-8 thc
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN113603568A (zh) * 2021-07-19 2021-11-05 厦门朝阳生物工程有限公司 一种大麻二酚的制备方法
WO2023086447A2 (en) * 2021-11-12 2023-05-19 Pureform Global, Inc. A method for the synthesis of cannabinol
WO2024028516A1 (en) 2022-08-05 2024-02-08 Salud & Semillas, S.L. CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473075A (de) 1966-11-04 1969-05-31 Theodor Dr Petrzilka Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten
DE4100441A1 (de) 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
WO2001003690A1 (en) 1999-07-12 2001-01-18 Virginia Commonwealth University Novel vasodilator cannabinoid analogs
US8034843B2 (en) * 2002-02-01 2011-10-11 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB2393182B (en) * 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
JP2007501279A (ja) * 2003-05-20 2007-01-25 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデイション カンナビノイド誘導体、その製造方法、および使用
US7323576B2 (en) 2004-10-01 2008-01-29 Alphora Research Inc. Synthetic route to dronabinol
TWI369203B (en) * 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
DE102005028937B4 (de) * 2005-06-22 2009-07-23 Bionorica Ag Verfahren zur Herstellung von Dronabinol
JP2009510078A (ja) 2005-09-29 2009-03-12 エーエムアール テクノロジー インコーポレイテッド Δ−９−テトラヒドロカンナビノールの生成法
WO2009099868A1 (en) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
PL3274321T3 (pl) * 2015-03-23 2020-03-31 Echo Pharmaceuticals B.V. Izolat kannabidiolu z konopi przemysłowych i jego zastosowanie w preparatach farmaceutycznych i/lub kosmetycznych
JP6899506B2 (ja) * 2015-05-28 2021-07-07 フレッシュ・カット・ディベロップメント・エル・エル・シー 安定なカンナビノイド製剤
US10059683B2 (en) * 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Also Published As

Publication number Publication date
CA2992043A1 (en) 2017-01-19
EP3722276A1 (en) 2020-10-14
AU2016294264B2 (en) 2019-06-13
US20170008869A1 (en) 2017-01-12
CA2992043C (en) 2020-04-14
CN108137526A (zh) 2018-06-08
DK3319952T3 (da) 2020-03-23
JP2020037596A (ja) 2020-03-12
AU2019229416A1 (en) 2019-10-03
US20170008868A1 (en) 2017-01-12
CL2019003154A1 (es) 2020-03-06
NZ738925A (en) 2019-05-31
US20180319763A1 (en) 2018-11-08
CO2018001290A2 (es) 2018-04-19
JP6810842B2 (ja) 2021-01-13
BR112018000497A2 (pt) 2018-09-11
US10059683B2 (en) 2018-08-28
EP3319952A1 (en) 2018-05-16
PT3319952T (pt) 2020-04-22
ES2784881T3 (es) 2020-10-01
WO2017011210A1 (en) 2017-01-19
JP2018522944A (ja) 2018-08-16
CR20180094A (es) 2018-06-14
US10844035B2 (en) 2020-11-24
ECSP18010065A (es) 2018-05-31
HK1255390A1 (zh) 2019-08-16
IL256750A (en) 2018-03-29
CL2018000079A1 (es) 2018-08-24
PH12018500093A1 (en) 2018-07-09
EP3319952B1 (en) 2020-02-05
US20210061781A1 (en) 2021-03-04
AU2016294264A1 (en) 2018-02-01
EP3319952B8 (en) 2020-03-11
MY182971A (en) 2021-02-05

Similar Documents

Publication Publication Date Title
PH12018500093A1 (en) Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
PH12017501445A1 (en) Methods for producing virus for vaccine production
MX2015016947A (es) Metodos para producir derivados de acido graso omega-hidroxilados.
RU2012110715A (ru) Способ получения микрокапсул
MY197904A (en) Method for producing substituted 5-fluoro-1h-pyrazolopyridines
BR112016009365A2 (pt) Método para aumentar, melhorar e estender a produção de etanol e método para diminuir as concentrações finais de dp2 em um produto de fermentação
MY190659A (en) Method for producing biohydrocarbons
EA201691649A1 (ru) Способ получения противогрибковых соединений
EA201691648A1 (ru) Способ получения противогрибковых соединений
EA033293B1 (ru) Рекомбинантный микроорганизм, экспрессирующий аналог авермектина, и его применение
MX2019011730A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
BR112016013316A8 (pt) método para a produção de furfural e uso de ácido metanossulfônico
MY183026A (en) Method for producing conjugated diene
MX2014014370A (es) Proceso para la produccion de metil metacrilato.
MX2018002555A (es) Vidrio de seguridad y procesamiento para su obtencion.
BR112016016397A2 (pt) método para preparar 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carbaldeídos e 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carboxilatos.
BR112016018594B8 (pt) Método para produção do derivado de 2-aciliminopiridina
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
IN2014DN07656A (es)
BR112017006967A2 (pt) produção aperfeiçoada de 5-hidroximetilfurfural, sob uso de um composto de álcool multifluorado
IN2014DN07407A (es)
WO2016207711A8 (ja) 変性リグニン、エポキシ樹脂、及びその製造方法
MY174840A (en) Microorganism producing o-acetyl-homoserine, and method for producing o-acetyl-homoserine by using same
MY175821A (en) Microorganism having ability to produce o-succinylhomoserine or succinic acid, and method for producing succinic acid or o-succinylhomoserine by using same